| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/08/2013 | CN102453079B Peptide specifically binding basic fibroblast growth factor receptor |
| 05/08/2013 | CN102450718B Pulse sports beverage and preparation method thereof |
| 05/08/2013 | CN102309745B Glycoprotein composition which almost does not contain subunit |
| 05/08/2013 | CN102309744B Composition of glycoprotein contains hardly subunit |
| 05/08/2013 | CN102304178B Preparation method and application of African clawed toad antitumor polypeptide |
| 05/08/2013 | CN102292086B Pharmaceutical composition |
| 05/08/2013 | CN102286071B Cyclic tetrapeptide compound and preparation method and use thereof |
| 05/08/2013 | CN102190708B Barrel-shaped alpha conantokin Bt1.3 and application thereof |
| 05/08/2013 | CN102100908B Protein composition |
| 05/08/2013 | CN101928342B High-purity menopausal gonadotropin as well as preparation method and application thereof |
| 05/08/2013 | CN101766228B Iimmune stimulatory infant nutrition |
| 05/08/2013 | CN101712964B Fusion protein for inhibiting formation of osteoclast and preparation method as well as pharmaceutical composition thereof |
| 05/08/2013 | CN101641368B Method for producing soluble thrombomodulin of high purity |
| 05/08/2013 | CN101588818B Peptide chimeric molecules having antiviral properties against viruses of the flaviviridae family |
| 05/08/2013 | CN101560546B Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha |
| 05/08/2013 | CN101522022B Products and methods using soy peptides to lower total and LDL cholesterol levels |
| 05/08/2013 | CN101284146B Dry hemostatic compositions and methods for their preparation |
| 05/08/2013 | CN101257914B Composition for amelioration of body lipid |
| 05/08/2013 | CN101254300B Intestinotrophic glucagon-like peptide-2 analogs |
| 05/08/2013 | CN101128213B Promoter of regeneration of pancreatic beta cell, and promoter of insulin production in pancreatic beta cell |
| 05/07/2013 | US8436163 Splice-region antisense composition and method |
| 05/07/2013 | US8436148 Antibodies against interleukin-18 binding protein, their preparation and use |
| 05/07/2013 | US8436142 Processing of recombinant human G-CSF precursor |
| 05/07/2013 | US8436141 Purified hemocyanin obtained from Fissurella latimarginata; subunit of purified hemocyanin; use of hemocyanin, its subunit or immunogenic fragments and compositions containing the same |
| 05/07/2013 | US8436138 Binder for C-reactive protein |
| 05/07/2013 | US8436137 Selective anticancer chimeric peptide comprising an EGF receptor-binding peptide and a cytotoxic peptide |
| 05/07/2013 | US8436136 Peptide complex |
| 05/07/2013 | US8436135 Diagnosis and risk stratification by determining the marker CT-proADM |
| 05/07/2013 | US8436021 Pharmaceutical composition for treating and/or preventing a pathology associated with an obsessional behavior or with obesity |
| 05/07/2013 | US8435956 Compositions and methods for protecting cells from toxic exposures |
| 05/07/2013 | US8435954 Azapeptides as CD36 binding compounds |
| 05/07/2013 | US8435953 Sustained release composition containing SDF-1 |
| 05/07/2013 | US8435952 Method for retarding progression to definite rheumatoid arthritis in subjects with undifferentiated arthritis |
| 05/07/2013 | US8435950 Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same |
| 05/07/2013 | US8435949 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis |
| 05/07/2013 | US8435948 Follicle stimulating hormone (Fsh); bioavailability; drug screening |
| 05/07/2013 | US8435947 Endothelial nitric oxide synthase antagonists and uses thereof for inhibiting oxygen toxicity |
| 05/07/2013 | US8435946 Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form |
| 05/07/2013 | US8435945 GH secretagogues and uses thereof |
| 05/07/2013 | US8435944 Method and composition for transdermal drug delivery |
| 05/07/2013 | US8435943 Protein stabilization formulations |
| 05/07/2013 | US8435942 Methods for formulating stabilized insulin compositions |
| 05/07/2013 | US8435941 Mini-hepcidin peptides and methods of using thereof |
| 05/07/2013 | US8435939 Polypeptide anti-HIV agent containing the same |
| 05/07/2013 | US8435938 Pure vancomycin hydrochloride |
| 05/07/2013 | US8435937 Inhibition of migration and induction of cell death by the type II collagen amino propeptides |
| 05/07/2013 | US8435801 Methods and compositions for the production of monoclonal antibodies |
| 05/07/2013 | US8435779 Process for producing a virus-inactivated thrombin preparation |
| 05/07/2013 | US8435574 Compositions for alleviating inflammation and oxidative stress in a mammal |
| 05/07/2013 | US8435554 Compositons for nasal administration of pharmaceuticals |
| 05/07/2013 | US8435552 Collagen/hydroxyapatite composite scaffold, and process for the production thereof |
| 05/07/2013 | US8435540 Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in VIVO |
| 05/07/2013 | US8435539 Delivery system for cytotoxic drugs by bispecific antibody pretargeting |
| 05/07/2013 | US8435532 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis |
| 05/07/2013 | US8435522 Humanized antibodies against CXCR3 |
| 05/07/2013 | US8435520 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
| 05/07/2013 | US8435515 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
| 05/07/2013 | US8435491 Quantification method for remaining liver function and novel liver receptor imaging agent |
| 05/07/2013 | CA2659664C Improved radiation therapy methods |
| 05/07/2013 | CA2647988C Interleukin production regulator, pharmaceutical composition, food, and drink containing interleukin production regulator, and production method thereof |
| 05/07/2013 | CA2516651C Methods of screening for trpm5 modulators |
| 05/07/2013 | CA2496376C Methods of drug delivery using sulphated chitinous polymers |
| 05/07/2013 | CA2486714C Compositions for penis enlargement |
| 05/07/2013 | CA2475073C Hypoallergenic polypeptides based on fish parvalbumin |
| 05/07/2013 | CA2467195C Matrix for the production of tissue engineered ligaments, tendons and other tissue |
| 05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/07/2013 | CA2397030C Methods for treating pancreatic disorders |
| 05/07/2013 | CA2360347C Improved expression of hiv polypeptides and production of virus-like particles |
| 05/02/2013 | WO2013063615A2 N-acyldipeptide derivatives and their uses |
| 05/02/2013 | WO2013063572A1 Ultra-concentrated rapid-acting insulin analogue formulations |
| 05/02/2013 | WO2013063557A1 Treatment of il-17 mediated disease by blocking sefir-sefir interactions |
| 05/02/2013 | WO2013063527A1 Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and t2d |
| 05/02/2013 | WO2013063482A2 Flt3 mutations associated with drug resistance in aml patients having activating mutations in flt3 |
| 05/02/2013 | WO2013063405A1 Methods of treating gram-negative microbial infections |
| 05/02/2013 | WO2013063312A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer |
| 05/02/2013 | WO2013063309A1 Gigaxonin fusion protein and methods for treating giant axonal neuropathy |
| 05/02/2013 | WO2013063243A1 Small molecule malarial aldolase-trap enhancers and glideosome inhibitors |
| 05/02/2013 | WO2013063160A1 Methods and compositions for treating pain |
| 05/02/2013 | WO2013063155A2 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
| 05/02/2013 | WO2013063120A2 Nmda receptor modulators and uses thereof |
| 05/02/2013 | WO2013063086A1 Compositions and methods for treatment of proteinopathies |
| 05/02/2013 | WO2013063046A1 Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors |
| 05/02/2013 | WO2013063001A1 Therapeutic combinations and methods of treating melanoma |
| 05/02/2013 | WO2013062995A1 Compositions and methods for treating deep partial and full thickness wounds and injuries |
| 05/02/2013 | WO2013062994A1 Compositions and methods for treating full thickness burn injuries |
| 05/02/2013 | WO2013062959A2 Continuous subcutaneous administration of interferon-alpha to hepatitis b infected patients |
| 05/02/2013 | WO2013062445A1 Pharmaceutical composition and kit for treating bacterial infections |
| 05/02/2013 | WO2013062444A1 Peptide azemiopsin selectively interacting with nicotinic acetylcholine receptors of muscle type |
| 05/02/2013 | WO2013062305A1 Method for preparing highly concentrated fibrinogen solution and method for preparing fibrin sealant by using thereof |
| 05/02/2013 | WO2013061818A1 Novel peptide complex and hybrid complex thereof, and use of said hybrid complex |
| 05/02/2013 | WO2013061594A1 Topk peptides and vaccines including the same |
| 05/02/2013 | WO2013061112A1 Use of egfl7 modulators for promoting or inhibiting migration of immune cells across vascular endothelium |
| 05/02/2013 | WO2013061106A1 Modified peptide toxins |
| 05/02/2013 | WO2013060887A1 A polypeptide for the protection against heart ischemia-reperfusion injury |
| 05/02/2013 | WO2013060864A1 Chimeric molecule involving oligomerized fasl extracellular domain |
| 05/02/2013 | WO2013060850A1 Treatment protocol of diabetes type 2 |
| 05/02/2013 | WO2013060770A1 Hemostatic compositions |
| 05/02/2013 | WO2013060759A1 Dietary product intended to reduce visceral fat during the pre-operative phase prior to bariatric surgery |
| 05/02/2013 | WO2013060758A1 Dietary product intended for the prevention of cardiometabolic risk |
| 05/02/2013 | WO2013060303A1 Polypeptides inhibiting neovascularization and uses thereof |